DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 61 filers reported holding DESIGN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,876,702 | -32.6% | 5,032,501 | +79.9% | 1.58% | -33.9% |
| Q2 2023 | $17,624,256 | +9.2% | 2,797,501 | 0.0% | 2.40% | +3.8% |
| Q1 2023 | $16,141,581 | -43.8% | 2,797,501 | 0.0% | 2.31% | -31.3% |
| Q4 2022 | $28,702,360 | -38.6% | 2,797,501 | 0.0% | 3.36% | -41.5% |
| Q3 2022 | $46,774,000 | +19.4% | 2,797,501 | 0.0% | 5.75% | -20.0% |
| Q2 2022 | $39,165,000 | -13.3% | 2,797,501 | 0.0% | 7.18% | +22.7% |
| Q1 2022 | $45,180,000 | -23.9% | 2,797,501 | +0.9% | 5.86% | -4.3% |
| Q4 2021 | $59,359,000 | +45.7% | 2,772,501 | 0.0% | 6.12% | +108.4% |
| Q3 2021 | $40,728,000 | -25.1% | 2,772,501 | +1.5% | 2.94% | -35.7% |
| Q2 2021 | $54,349,000 | -33.5% | 2,732,501 | 0.0% | 4.57% | -42.7% |
| Q1 2021 | $81,702,000 | – | 2,732,501 | – | 7.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $15,402,483 | 7.89% |
| Logos Global Management LP | 5,032,501 | $11,876,702 | 1.58% |
| Prosight Management, LP | 1,203,745 | $2,840,838 | 0.90% |
| TANG CAPITAL MANAGEMENT LLC | 1,350,000 | $3,186,000 | 0.45% |
| Soleus Capital Management, L.P. | 1,025,000 | $2,419,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,512,986 | $5,930,647 | 0.12% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 180,000 | $425,000 | 0.09% |
| Corton Capital Inc. | 27,134 | $64,036 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,722 | $237,704 | 0.03% |
| Rock Springs Capital Management LP | 460,391 | $1,086,523 | 0.03% |